Dalargin and liver function during acute hypoxia
V. Yu. Kalinin · 2000 · Candidate dissertation, 2000; web transcription
What does this source report?
The dissertation transcription reports longer survival in severe hypobaric hypoxia at testing times through 168 hours after ordinary intravenous administration and through 336 hours with erythrocyte-carrier delivery. Liver and oxidative-stress markers varied by delivery method and time.
- Population and setting
- Rats; pressure-chamber model reported as approximately 12,200 m
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Rat experiments do not establish human altitude protection or a seven-day clinical effect.
- Original scan and survival tables remain to be reconciled; numerical survival values are withheld.
- The early time point appears as 0.15 hours in the transcription; it is not safely interpretable as 15 minutes.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Selected text reviewed
Source access and review scope
Selected source text and metadata checked; full risk-of-bias review pending.
Recorded source-check date: 2026-10-04. This date does not imply a completed systematic review.
Cite and trace this record
Original source: V. Yu. Kalinin. Dalargin and liver function during acute hypoxia Candidate dissertation, 2000; web transcription 2000.
Molekul research summary: https://molekul.io/research/dalargin-hypoxia-kalinin-2000. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry